Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Drinks | Retail | Videos
Condiments & Ingredients
Ingredients
Return to: FBR Home | Condiments & Ingredients | Ingredients

Nestle, Nuritas partner to discover food-derived bioactive peptides through AI

Published 09 February 2018

Food giant Nestle has entered into a partnership with Nuritas to discover food-derived bioactive peptides within specific target areas using artificial intelligence (AI) and genomics.

In order to achieve the common goal, Nuritas will deploy its award-winning and novel technology platform, which uses Artificial Intelligence and DNA analysis to predict, unlock, and validate highly efficacious peptides, exclusively from natural food sources.

Nestlé will use their considerable scientific know-how and applications expertise to validate the efficacy of these new discoveries within the target applications.

Nuritas founder and chief scientific officer Nora Khaldi said: “At Nuritas our mission is to positively impact billions of lives worldwide and we therefore are delighted to be collaborating with Nestlé, the world’s largest food and beverage company on such an important project. We are really looking forward to beginning this impactful journey together.”

Nestlé Research Centre’s Richard Stadler said: “As our understanding of food and nutrition continues to grow, our global research and development network is looking ahead to discover how we can help enhance quality of life and contribute to a healthier future for everyone. Research partnerships such as that with Nuritas help us achieve that goal.”

Nuritas CEO Emmet Browne said: “The fruition of our collaboration carries the promise to be truly industry-changing.

“We are very excited to partner with Nestle as they look to continue their own admirable purpose to help shape a better and healthier world.”

Nuritas is a rapidly growing, award-winning digital biotechnology and R&D company which has created remarkable interest globally for its peptide-finding platform capabilities.



Source: Company Press Release